PRESS RELEASE published on 01/26/2024 at 14:00, 2 years 1 month ago Optimind Pharma - Debenture Conversion Optimind Pharma Corp. (CSE:OMND) announces agreement to convert $303,750 convertible debentures at $0.025/share, potentially issuing 23,333,500 shares. Optimind focuses on psychedelic therapies for mental health. Convertible Debentures Optimind Pharma Corp. CSE:OMND Psychedelic Therapies Mental Health
PRESS RELEASE published on 12/19/2023 at 13:30, 2 years 3 months ago Optimind Pharma Provides Corporate Update
Published on 03/26/2026 at 13:00, 11 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 11 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 12 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 26 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 12:45, 26 minutes ago Electric Royalties Provides Update on Critical Metals Royalty Portfolio
Published on 03/26/2026 at 13:00, 11 minutes ago Nebius AI Cloud 3.5 introduces serverless AI to give developers frictionless compute for real-world AI
Published on 03/26/2026 at 12:45, 25 minutes ago Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy
Published on 03/26/2026 at 12:20, 50 minutes ago North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million
Published on 03/26/2026 at 12:17, 53 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 03/26/2026 at 07:30, 5 hours 41 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 18 hours 40 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 19 hours 26 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
